Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: filgrastim
Biological: rituximab
Biological: sargramostim
Drug: carmustine
Drug: cytarabine
Drug: etoposide
Drug: melphalan
Procedure: autologous hematopoietic stem cell transplantation

First Posted Date: 2007-08-27

Last Posted Date: 2015-12-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 14

Registration Number: NCT00521014

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women

Completed

Conditions: Psychosocial Effects of Cancer and Its Treatment
Breast Cancer

First Posted Date: 2007-08-23

Last Posted Date: 2015-10-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT00519974

Locations: 🇺🇸
New School for Social Research, New York, New York, United States
🇺🇸
SHARE, Incorporated, New York, New York, United States
🇺🇸
Ralph Lauren Center for Cancer Care and Prevention, New York, New York, United States

and more 3 locations

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

Completed

Conditions: Survivors
Psychological Factors
Melanoma

Interventions: Behavioral: Focus group
Behavioral: Survey

First Posted Date: 2007-08-17

Last Posted Date: 2015-07-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 160

Registration Number: NCT00518050

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, New York, United States

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Phase 2

Completed

Conditions: Gastroesophageal Junction Adenocarcinoma
Gastric Cancer

Interventions: Drug: Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen
Drug: Docetaxel, Leucovorin, Fluorouracil, Cisplatin
Drug: Docetaxel, Leukvorin, Flurouracil, Cisplatin, Trastuzumab

First Posted Date: 2007-08-13

Last Posted Date: 2019-12-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 111

Registration Number: NCT00515411

Locations: 🇺🇸
Nebraska Cancer Specialists, Methodist Estabrook Cancer Center, Omaha, Nebraska, United States
🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
University Hospital of Cleveland, Cleveland, Ohio, United States

and more 12 locations

Risk Factors for Endometrial Cancer in Black Women

Active, not recruiting

Conditions: Endometrial Cancer

Interventions: Other: questionnaire administration
Other: study of socioeconomic and demographic variables
Procedure: evaluation of cancer risk factors

First Posted Date: 2007-08-09

Last Posted Date: 2024-08-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 59

Registration Number: NCT00514254

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
City College of New York, New York, New York, United States
🇺🇸
SUNY Downstate Medical Center, Brooklyn, New York, United States

and more 1 locations

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

Completed

Conditions: Hodgkin's Lymphoma
Leukemia
Non-Hodgkin's Lymphoma
Myelodysplastic Syndrome

Interventions: Other: Questionnaires, Laboratory tests, Abdominal MRI

First Posted Date: 2007-08-02

Last Posted Date: 2020-12-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT00510315

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Phase 2

Active, not recruiting

Conditions: Childhood Cancer
Multiple Diseases

Interventions: Biological: Immunization Schedule patients > or = to 11 years of age
Biological: Immunization Schedule patients <7 years.
Biological: Immunization Schedule patients > or = to 7 years and <11 years of age

First Posted Date: 2007-07-20

Last Posted Date: 2023-08-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 75

Registration Number: NCT00505063

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, New York, United States

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Not Applicable

Completed

Conditions: Vulvar Cancer

Interventions: Drug: imiquimod
Procedure: biopsy
Procedure: therapeutic conventional surgery

First Posted Date: 2007-07-19

Last Posted Date: 2018-06-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 8

Registration Number: NCT00504023

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

Not Applicable

Conditions: Prostate Cancer
Psychosocial Effects of Cancer and Its Treatment
Sexual Dysfunction and Infertility
Sexuality and Reproductive Issues

First Posted Date: 2007-07-19

Last Posted Date: 2013-09-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 100

Registration Number: NCT00503646

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: temozolomide
Genetic: protein expression analysis
Genetic: reverse transcriptase-polymerase chain reaction
Other: diagnostic laboratory biomarker analysis
Other: immunoenzyme technique

First Posted Date: 2007-07-11

Last Posted Date: 2016-02-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 47

Registration Number: NCT00498927

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy